Aesthetic providers have a new tool available to increase patient comfort during minimally invasive cosmetic treatments. Pliaglis, a topical lidocaine and tetracaine (7%/7%) cream that, once applied to a patient’s skin, dries to form a pliable layer that is peeled off once the skin is numbed, is now available in the United States. The FDA-approved topical anesthetic, which is distributed by Taro Pharmaceuticals, can be used on intact skin prior to superficial dermatological procedures, such as dermal filler injections, pulsed dye laser therapy, laser skin resurfacing and laser-assisted tattoo removal. For more information, visit www.taro.com.
Pliaglis Anesthetic Now in U.S.
Mar 29th, 2018